OBJECTIVES: Increased maternal serum bile acids are implicated in intrahepatic cholestasis of pregnancy. Individual bile acid profiles and their relationship with disease progression, however, remain unknown. The purpose of this prospective study was to determine the temporal changes in bile acids in normal pregnancy and in pregnancies complicated with intrahepatic cholestasis of pregnancy and pruritus gravidarum. METHODS: A validated method for the evaluation of 15 bile acids (conjugated and unconjugated) in a single serum sample was developed using high-performance liquid chromatography/mass spectrometry (HPLC-MS) with an electrospray interface. Bile acid concentrations were assessed in samples (16 weeks of gestation to 4 weeks postpartum) from women with, or who later developed, intrahepatic cholestasis of pregnancy (n=63) and were compared with those from normal pregnant women (n=26) and from women with pruritus gravidarum (n=43). RESULTS: Intrahepatic cholestasis of pregnancy was associated with a predominant increase in cholic acid conjugated with taurine and glycine, from 24 weeks of pregnancy. Ursodeoxycholic acid (UDCA) treatment (> or =21 days, n=15) significantly reduced serum taurocholic and taurodeoxycholic acid concentrations (P<0.01). Bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. CONCLUSIONS: The bile acid profiles and effects of treatment by UDCA implicate a role for taurine-conjugated bile acids in the syndrome of intrahepatic cholestasis of pregnancy. [corrected] With regard to individual bile acid profiles, pruritus gravidarum is a disorder quite distinct from intrahepatic cholestasis of pregnancy.
OBJECTIVES: Increased maternal serum bile acids are implicated in intrahepatic cholestasis of pregnancy. Individual bile acid profiles and their relationship with disease progression, however, remain unknown. The purpose of this prospective study was to determine the temporal changes in bile acids in normal pregnancy and in pregnancies complicated with intrahepatic cholestasis of pregnancy and pruritus gravidarum. METHODS: A validated method for the evaluation of 15 bile acids (conjugated and unconjugated) in a single serum sample was developed using high-performance liquid chromatography/mass spectrometry (HPLC-MS) with an electrospray interface. Bile acid concentrations were assessed in samples (16 weeks of gestation to 4 weeks postpartum) from women with, or who later developed, intrahepatic cholestasis of pregnancy (n=63) and were compared with those from normal pregnant women (n=26) and from women with pruritus gravidarum (n=43). RESULTS:Intrahepatic cholestasis of pregnancy was associated with a predominant increase in cholic acid conjugated with taurine and glycine, from 24 weeks of pregnancy. Ursodeoxycholic acid (UDCA) treatment (> or =21 days, n=15) significantly reduced serum taurocholic and taurodeoxycholic acid concentrations (P<0.01). Bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. CONCLUSIONS: The bile acid profiles and effects of treatment by UDCA implicate a role for taurine-conjugated bile acids in the syndrome of intrahepatic cholestasis of pregnancy. [corrected] With regard to individual bile acid profiles, pruritus gravidarum is a disorder quite distinct from intrahepatic cholestasis of pregnancy.
Authors: N Janzen; S Sander; M Terhardt; A M Das; J O Sass; R Kraetzner; H Rosewich; H Rosevich; M Peter; J Sander Journal: J Lipid Res Date: 2010-01-21 Impact factor: 5.922
Authors: Kejun Zhou; Na Lin; Yongtao Xiao; Yang Wang; Jie Wen; Gang-Ming Zou; Xuefan Gu; Wei Cai Journal: PLoS One Date: 2012-11-14 Impact factor: 3.240
Authors: Jocelyn Trottier; Andrzej Białek; Patrick Caron; Robert J Straka; Piotr Milkiewicz; Olivier Barbier Journal: PLoS One Date: 2011-07-08 Impact factor: 3.240
Authors: Richard D Beger; Sudeepa Bhattacharyya; Xi Yang; Pritmohinder S Gill; Laura K Schnackenberg; Jinchun Sun; Laura P James Journal: Arch Toxicol Date: 2015-05-17 Impact factor: 5.153
Authors: Yuanyuan Zhang; Fei Li; Yao Wang; Aaron Pitre; Zhong-Ze Fang; Matthew W Frank; Christopher Calabrese; Kristopher W Krausz; Geoffrey Neale; Sharon Frase; Peter Vogel; Charles O Rock; Frank J Gonzalez; John D Schuetz Journal: Nat Commun Date: 2015-09-29 Impact factor: 14.919
Authors: Peter H Dixon; Christopher A Wadsworth; Jennifer Chambers; Jennifer Donnelly; Sharon Cooley; Rebecca Buckley; Ramona Mannino; Sheba Jarvis; Argyro Syngelaki; Victoria Geenes; Priyadarshini Paul; Meera Sothinathan; Ralf Kubitz; Frank Lammert; Rachel M Tribe; Chin Lye Ch'ng; Hanns-Ulrich Marschall; Anna Glantz; Shahid A Khan; Kypros Nicolaides; John Whittaker; Michael Geary; Catherine Williamson Journal: Am J Gastroenterol Date: 2013-12-24 Impact factor: 10.864